A system to prevent suicide in Black youth
Official title: Answering the Alarm: A System of Care for Black Youth at Risk for Suicide
Run by New York University · NCT05654207 · Data updated 2026-11-12
This study is testing a new care system called WeCare to see if it can help reduce suicide risk among Black youth by providing better support and screening in emergency departments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years to 19 Years |
| Sex | All |
| Enrollment | 2200 (estimated) |
| Sponsor | New York University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | April 8, 2024 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | June 10, 2026 |
| Trial ID | NCT05654207 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Black adolescents aged 12-19 who present to emergency departments with suicidal ideation and have a parent or guardian available to provide consent.
✕Probably not a fit
Patients who are medically unstable, have severe cognitive impairments, or are currently receiving mental health treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to address the rising rates of suicidal ideation among Black youth by implementing a comprehensive care system called WeCare. The approach includes universal screening for suicide risk using the Computerized Adaptive Screen for Suicidal Youth (CASSY), a brief intervention tailored for Black adolescents in emergency departments, and supportive text messaging for both youth and their caregivers. The study will evaluate the effectiveness of this multi-faceted strategy in improving suicide risk detection and providing necessary support. By integrating input from various stakeholders, the study seeks to enhance the implementation of this intervention.
Why it matters
Potential benefit: If successful, this approach could significantly reduce suicidal ideation and improve mental health outcomes for Black youth.
How similar studies have gone: Other studies have shown promise in using similar multi-component interventions for suicide prevention, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria adolescent and parent/guardians: * Adolescents aged 12-17 years and their parents or guardians, and adolescents 18-19 years who have the option for their parent or guardian to participate * Having a parent/caregiver present in the ED to consent or available to consent remotely (12-17 year olds, only) * Having a cellular phone with text messaging capacity * Adolescent able to speak English, and understand study questions * Parents able to consent in English, Spanish, French or Creole * Meet screening criteria Exclusion criteria adolescent and parent/guardians: * Adolescent is medically unstable * Adolescent present with severe cognitive impairment * Parents are not present in the ED, unable to consent remotely, and not able to give consent in either English, Spanish, French or Creole (12-17 year olds, only) * Adolescent does not have access to cellular phone * Adolescents active in mental health treatment (e.g., seen a therapist, social worker, or mental health provider in the last week)
Where it's running
-
Kings County Hospital
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Michael A Lindsey, PhD — New York University
- Study coordinator: Michael A Lindsey, PhD
- Email: michael.lindsey@nyu.edu
- Phone: (212) 998-5959
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multi-layered digital monitoring and pharmacogenomics to prevent suicide in adults with depression
This study tests whether a digital monitoring system, a digital safety plan, and pharmacogenetic-guided care can reduce suicide re-attempts in adults with depression.
-
Rapid relief of suicidal thoughts with ketamine and a crisis plan in the emergency department
This study tests whether a single intramuscular dose of ketamine plus a brief Crisis Response Plan helps reduce suicidal thoughts in ED patients who are likely to be admitted.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Reward Sensitivity Digital App for Adolescent Suicidal Thoughts
A smartphone app is tested in teens to see if daily check-ins and mood-building activities can reduce suicidal thoughts and improve mood.
-
Student Precarity and Psychiatry: How Financial Struggles Relate to Depression and Loneliness
This observational study looks at whether financial hardship and social isolation are linked to depression, suicidal thoughts, and loneliness among French university students.
-
Ketamine with DBT for suicidality in adults with treatment-resistant depression or bipolar disorder and BPD
This study tests whether four ketamine infusions plus Dialectical Behavioural Therapy can more quickly reduce suicidal thoughts in adults with Borderline Personality Disorder and treatment-resistant depression or bipolar disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.